Dalotuzumab
Drug timelines are a Plus or Pro feature.
14 regulatory and trial events tracked for Dalotuzumab, covering 2015-02-10 to 2020-05-04. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025) [Phase 2]